Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carmen Bollmann"'
Autor:
Claudia Döring, Katharina Peer, Katrin Bankov, Carmen Bollmann, Annette Ramaswamy, Pietro Di Fazio, Peter Johannes Wild, Detlef Klaus Bartsch
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCalcitonin-producing pancreatic neuroendocrine neoplasms (CT-pNENs) are an extremely rare clinical entity, with approximately 60 cases reported worldwide. While CT-pNENs can mimic the clinical and diagnostic features of medullary thyroid
Externí odkaz:
https://doaj.org/article/1fd221ac86a24c0dad070f97d2c3896a
Autor:
Ioannis Mintziras, Ulrike W Denzer, Detlef K. Bartsch, Jerena Manoharan, Sabine Wächter, Max B. Albers, Pietro Di Fazio, Martin Anlauf, Carmen Bollmann
Publikováno v:
Clinical Endocrinology. 95:439-446
Gastric enterochromaffin-like cell (ECL) tumours can occur in patients with multiple endocrine neoplasia type 1 (MEN1), especially in those affected by Zollinger Ellison syndrome (ZES). Since the prevalence of ECL lesions is not well defined yet, the
Autor:
Jerena Manoharan, Pietro Di Fazio, Peter H. Kann, Detlef K. Bartsch, Carmen Bollmann, Max B. Albers
Publikováno v:
Visc Med
Background: Some gender-related differences have been reported in multiple endocrine neoplasia type 1 (MEN1), although not all reports are conclusive. This systematic review with analysis of the own MEN1 cohort evaluates gender differences and potent
Autor:
Elisabeth Maurer, Carmen Bollmann, Jerena Manoharan, Sabine Wächter, Detlef K. Bartsch, Ioannis Mintziras, Max B. Albers
Publikováno v:
Clinical Endocrinology. 92:63-70
Importance Guidelines advocate subtotal parathyroidectomy (SPTX) or total parathyroidectomy with autotransplantation (TPTX) with bilateral cervical thymectomy for primary hyperparathyroidism (pHPT) associated with multiple endocrine neoplasia type 1
Autor:
Detlef K. Bartsch, Max B. Albers, Jerena Manoharan, Emily P. Slater, Volker Fendrich, Caroline L. Lopez, Barbara Joos, Carmen Bollmann, Aninja Bayer, Sylvia Roth
Publikováno v:
World Journal of Surgery. 43:831-838
Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms. We evaluated the chemopreventive effects of a long-acting somatostatin analogue on the development of pancreatic neuroendocrine neo
Autor:
Jerena Manoharan, Ioannis Mintziras, Pietro Di Fazio, Barbara Joos, Detlef K. Bartsch, Silvia Roth, Caroline L Lopez-Lopez, Chang X. Zhang, Philippe Bertolino, Emily P. Slater, Volker Fendrich, Carmen Bollmann, Max B. Albers, Annette Ramaswamy
Publikováno v:
Neuroendocrinology. 107:257-266
Pancreatic neuroendocrine neoplasias (pNEN) are the most common cause of death in adult patients with multiple endocrine neoplasia type 1 (MEN1). So far, only few chemopreventive strategies (e.g., with somatostatin analogues) have been evaluated for
Autor:
Caroline L. Lopez, Carmen Bollmann, Peter H. Kann, Detlef K. Bartsch, Jonas C. Apitzsch, Max B. Albers, Emily P. Slater, Damiano Librizzi, Jerena Manoharan
Publikováno v:
World Journal of Surgery. 41:1521-1527
Routine screening is recommended for patients with multiple endocrine neoplasia type 1 (MEN1) to enable early detection and treatment of associated neuroendocrine neoplasms (NEN). GalliumBetween January 2014 and March 2016, all MEN1 patients underwen
Autor:
Jerena Manoharan, Carmen Bollmann, K Holzer, Max B. Albers, Detlef K. Bartsch, Maximilian P. Chlosta
Publikováno v:
World journal of surgery. 43(2)
To evaluate the outcome of duodenopancreatic reoperations in patients with multiple endocrine neoplasia type 1 (MEN1). MEN1 patients who underwent reoperations for duodenopancreatic neuroendocrine neoplasms (dpNENs) were retrieved from a prospective
Autor:
Carmen Bollmann, Jerena Manoharan, Emily P. Slater, Volker Fendrich, Friedhelm Raue, Detlef K. Bartsch, Caroline L. Lopez, Max B. Albers
Publikováno v:
World journal of surgery. 41(8)
Recent clinical practice guidelines recommend that routine screening of MEN1 mutation carriers should start at the age of 5 years. The occurrence of clinically relevant MEN1 organ manifestations in children (≤18 years) was evaluated. Two prospectiv
Autor:
Volker Fendrich, Jens Waldmann, Caroline L. Lopez, Detlef K. Bartsch, Carmen Bollmann, Max B. Albers, Jerena Manoharan
Publikováno v:
133. Kongress der Deutschen Gesellschaft für Chirurgie; 20160426-20160429; Berlin; DOC16dgch493 /20160421/
Background: The role of minimally invasive pancreatic surgery for pancreatic neuroendocrine neoplasms (pNENs) in patients with multiple endocrine neoplasia type 1 (MEN1) is not well defined. The aim of this study was to compare the outcome of minimal